Spyros Papapetropoulos - Insider Trading & Ownership

Location
C/O Adamas Pharmaceuticals, Inc., 1900 Powell St., Suite 1000, Emeryville, CA
Summary
The estimated net worth of Spyros Papapetropoulos is at least $1.79M dollars as of September 2, 2025. Spyros Papapetropoulos is the Chief Medical Officer of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $1.15M. Spyros Papapetropoulos is the President and CEO, Director of Neuphoria Therapeutics Inc. and owns shares of Neuphoria Therapeutics Inc. (NEUP) stock worth about $613K. Spyros Papapetropoulos is the Director of Lipocine Inc. and owns shares of Lipocine Inc. (LPCN) stock worth about $23K.
Signature
/s/ Spyros Papapetropoulos
All Insider Reports
All Insider Reports

Ownership of Spyros Papapetropoulos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VIGL Vigil Neuroscience, Inc. Chief Medical Officer $1.15M Nov 18, 2022
NEUP Neuphoria Therapeutics Inc. President and CEO, Director $613K Aug 27, 2025
LPCN Lipocine Inc. Director $23K Jun 4, 2025
ADMS Adamas Pharmaceuticals Inc Director Nov 24, 2021

Insider Transactions Reported by Spyros Papapetropoulos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.